XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Impact of ASU No. 2022-02 Adoption
Common stock
Additional paid-in capital
Unearned compensation
Retained earnings (deficit)
Retained earnings (deficit)
Impact of ASU No. 2022-02 Adoption
Accumulated other comprehensive (loss)
Treasury stock
Balance at beginning of period (in shares) at Dec. 31, 2021     48,667,000            
Balance at Beginning of Period at Dec. 31, 2021 $ 1,182,435   $ 528 $ 1,423,445 $ (9,056) $ (139,383)   $ (3,243) $ (89,856)
Comprehensive income (loss)                  
Net income 20,196         20,196      
Other comprehensive income (loss) (74,994)             (74,994)  
Total comprehensive income/(loss) (54,798)         20,196   (74,994)  
Cash dividends declared on common shares (6,152)         (6,152)      
Treasury shares repurchased (in shares)     (972,000)            
Treasury shares repurchased (29,254)               (29,254)
Forfeited shares (in shares)     (36,000)            
Forfeited shares 0     70 983       (1,053)
Exercise of stock options (in shares)     1,000            
Exercise of stock options 25         (4)     29
Restricted stock grants (in shares)     139,000            
Restricted stock grants 0     161 (4,016)       3,855
Stock-based compensation 1,805       1,805        
Other, net (in shares)     (7,000)            
Other, net (200)     3         (203)
Balance at end of period (in shares) at Mar. 31, 2022     47,792,000            
Balance at End of Period at Mar. 31, 2022 $ 1,093,861   $ 528 1,423,679 (10,284) (125,343)   (78,237) (116,482)
Balance at beginning of period (in shares) at Dec. 31, 2022 44,361,222   44,361,000            
Balance at Beginning of Period at Dec. 31, 2022 $ 954,062 $ 401 $ 528 1,424,183 (8,598) (71,428) $ 401 (181,052) (209,571)
Comprehensive income (loss)                  
Net income 27,637         27,637      
Other comprehensive income (loss) 21,986             21,986  
Total comprehensive income/(loss) 49,623         27,637   21,986  
Cash dividends declared on common shares (8,008)         (8,008)      
Treasury shares repurchased (in shares)     (47,000)            
Treasury shares repurchased (1,190)               (1,190)
Forfeited shares (in shares)     (31,000)            
Forfeited shares 0     87 834       (921)
Exercise of stock options (in shares)     0            
Exercise of stock options 0                
Restricted stock grants (in shares)     143,000            
Restricted stock grants 0     446 (4,352)       3,906
Stock-based compensation 1,196       1,196        
Other, net (in shares)     (15,000)            
Other, net $ (604)     (153)         (451)
Balance at end of period (in shares) at Mar. 31, 2023 44,411,346   44,411,000            
Balance at End of Period at Mar. 31, 2023 $ 995,480   $ 528 $ 1,424,563 $ (10,920) $ (51,398)   $ (159,066) $ (208,227)